Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001390777-25-000019
Filing Date
2025-01-23
Accepted
2025-01-23 14:13:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9460
2 EXHIBIT I 13G_Exhibit_I.txt EX-1 2430
3 POWER OF ATTORNEY POA.txt EX-2 14073
4 JOINT FILING AGREEMENT JFA.txt EX-3 12401
  Complete submission text file 0001390777-25-000019.txt   40171
Mailing Address 1275 MARKET STREET SAN FRANCISCO CA 94103
Business Address 1275 MARKET STREET SAN FRANCISCO CA 94103 415 558 0200
Dolby Laboratories, Inc. (Subject) CIK: 0001308547 (see all company filings)

EIN.: 900199783 | State of Incorp.: DE | Fiscal Year End: 0927
Type: SCHEDULE 13G | Act: 34 | File No.: 005-80595 | Film No.: 25549273
SIC: 6794 Patent Owners & Lessors
(CF Office: 05 Real Estate & Construction)

Mailing Address 240 GREENWICH STREET NEW YORK NY 10286
Business Address 240 GREENWICH STREET NEW YORK NY 10286 212-495-1784
Bank of New York Mellon Corp (Filed by) CIK: 0001390777 (see all company filings)

EIN.: 132614959 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6022 State Commercial Banks
(CF Office: 02 Finance)